2BB score and signals
Seres Therapeutics, Inc.’s current 2BB score is 22 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 15 | Very Weak |
| Quality | 80 | Very Strong |
| Risk | 53 | Moderate |
Company facts
| CEO | Eric Shaff |
| Founded | 2010 |
| Employees | 66 |
| 52-week range | $4.46 – $29.98 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-03 | — | -1.0251 | — | $6.48M |
| 2026-08-04 | — | -2.2287 | — | $182,580.00 |
| 2026-05-05 | -2.08 | -1.9176 | — | — |
| 2026-03-12 | -1.78 | -2.1522 | $438,000.00 | $0.00 |
Related companies
2BBBullish & Bearish